National Bank to buy Canadian Western Bank in C$5 bln deal-February 2024-www.financetom.com

National Bank to buy Canadian Western Bank in C$5 bln deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

National Bank to buy Canadian Western Bank in C$5 bln deal

Jun 11, 2024 2:07 PM

June 11 (Reuters) - National Bank of Canada ( NTIOF ) has

agreed to buy Canadian Western Bank ( CWESF ) in a deal valued at

C$5 billion, the companies said on Tuesday.

Previous page： Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida Next page： Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

Jan 7, 2025

ZURICH (Reuters) -Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a specialist in complex immune cell therapies to treat several types of blood cancer. Roche said it has accepted for payment nearly 65 million shares in Poseida - equivalent to 66% of the California company's stock - which had been tendered...

Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

Jan 7, 2025

ZURICH, Jan 8 (Reuters) - Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics ( PSTX ), a specialist in complex immune cell therapies to treat several types of blood cancer. Roche said it has accepted for payment nearly 65 million shares in Poseida - equivalent to 66% of the California company's stock...

Jan 7, 2025

...

Roche to complete acquisition of U.S. biopharma company Poseida

Jan 7, 2025

ZURICH, Jan 8 (Reuters) - Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics via its subsidiary Blue Giant Acquisition Corp. Roche said it has accepted for payment nearly 65 million shares in Poseida - equivalent to 66% of the California company's stock - which had been tendered by shareholders at a price...